Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2025 and Provides Update on Potential Best-in-Class Orexin Receptor 2 (OX2R) Agonist Program

Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc

Join Us for November’s Brown Bag Webinar – Navigating the Holidays with Narcolepsy

Wake Up Narcolepsy Inaugural Bridging Perspectives Convening Recap

Worldwide Step Up For Sleep 2025 Recap

Wake Up Narcolepsy Announces AASM Foundation 2026 Grant Partnership

Join Us for October’s Brown Bag Webinar – Advocating with Confidence in the Educational System

Jazz Pharmaceuticals Showcases Phase 4 Data Demonstrating Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Effects and Real-World Evidence at World Sleep and Psych Congresses

WUN Launches Translated Narcolepsy Resources Webpage for World Narcolepsy Day 2025

WUN Signs Community Support Letter for the Rare Pediatric Disease PRV Program